Company patents
LONZA LTD
LONZA LTD's patent strategy reveals a surprising shift away from its core Bioreactors / Cell Culture Apparatus, which constitutes 41.3% of its portfolio but has seen a consistent decline, including a -50.0% YoY drop in 2026 so far. Concurrently, there's an emerging focus on Pharmaceutical Preparations, experiencing a significant +100.0% YoY growth in 2026, and a notable resurgence in Fermentation & Biosynthesis with a +100.0% YoY increase in 2026, indicating a pivot towards downstream pharmaceutical development and bioprocess optimization despite overall portfolio contraction.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
63 US filings (since 2023) · 11 categories · 13 themes
Methods and systems for the efficient and scalable production, purification, and formulation of proteins and peptides, including fermentation, chromatography, and cell-based expression systems.
Systems and methods for automated monitoring and dynamic adjustment of environmental parameters (e.g., pH, temperature, oxygen, nutrients) and fluid handling within bioreactors to optimize cell/tissue growth or product synthesis.
Systems and components designed for mixing fluids in biological or pharmaceutical processes, often involving cell cultures, RNA synthesis, or nanoparticle formation, with considerations for sterility, automation, and precise control.
Modifying microorganisms, plant cells, or animal cells through genetic engineering to enhance or enable the biosynthesis of target compounds, often involving metabolic pathway engineering.
Methods and apparatus specifically tailored for the expansion, differentiation, or genetic modification of cells for therapeutic applications (e.g., CAR T cells, progenitor cells) or for the production of specific biological products (e.g., cultured fat, RNA).
Innovations in the physical design and modularity of bioreactor vessels and associated components, focusing on improved handling, scalability, perfusion, or integration within larger systems.
Methods and compositions for identifying, quantifying, or characterizing specific biological molecules (e.g., nucleic acids, proteins, metabolites, antibodies) or microbial species, often for diagnostic, prognostic, or quality control applications.
Development of therapeutic approaches involving the genetic modification of cells (e.g., T cells, stem cells, macrophages) or the use of viral/non-viral vectors to deliver genetic material for disease treatment.
Methods and systems for detecting fluid or gas leaks, or assessing the quality and continuity of seals in containers, systems, or structures. This often involves pressure changes, electrical properties, or acoustic analysis.
Development and use of engineered biological systems, such as organ-on-a-chip devices, dynamic hydrogels, or genetically modified cells, to mimic physiological conditions, study disease mechanisms, screen compounds, or develop cell-based therapies.
Design and modification of antibodies or antibody-derived fragments for targeted therapeutic intervention, including bispecific formats, Fc region modifications, and activatable constructs.
Design and engineering of proteins or peptides to directly modulate immune responses, including enhancing antigen presentation, suppressing inflammation, or activating specific immune cell types.
Devices and systems designed for the cultivation of cells or tissues, often incorporating three-dimensional structures or controlled interfaces to mimic in-vivo environments for biological research or production.
Patents
Showing 1-10 of 30
Automated Bioreactor Control